By combining our platform with Trialt’s expertise, we can support sponsors with both the technology and the operational ...
A majority of CKD patients present with cellular inflammation and immunoparalysis predose --Gemini durably normalizes ...
Sujay Jadhav, CEO of Verana Health highlights how real-time real-world data dashboards are transforming the way life sciences ...
PONTE VEDRA, Fla., March 28, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the ...
Ocugen Inc. (NASDAQ:OCGN) is one of the 10 best penny stocks that could triple your money. On March 24, Ocugen Inc. (NASDAQ:OCGN) announced 12-month data from the Phase 2 ArMaDa clinical trial ...
U.S. Food and Drug Administration (FDA) guidance states that payment for participation in clinical trials must be just, fair, and receive approval from an institutional review board (IRB). According ...
PALI-2108 demonstrated favorable safety and tolerability with no serious adverse events after two weeks of treatment in a difficult-to-treat population; Phase 1b data demonstrate ...
InvestorsHub on MSN
Connect Biopharma shares jump after encouraging clinical data
Shares of Connect Biopharma Holdings Limited (NASDAQ:CNTB) climbed about 11% after the company released positive findings ...
Electronic Health Records (EHRs) have transformed the landscape of clinical research by providing vast, longitudinal datasets that reflect real-world clinical practice. Their integration into research ...
Twenty-four of 58 adults (41%) and 29 of 56 children (52%) had a BICR-confirmed objective response during the 24-cycle treatment phase; in addition, two adults and one child had confirmed responses ...
The FDA has approved a drug for patients who are 12 and older with classical Hodgkin lymphoma based on the results of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results